Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
GOLDMAN SACHS GROUP INC - Former 10% Owner at Attovia Therapeutics, Inc.
Issuer-level insider activity
- Role
- Former 10% Owner
- Issuer ticker
- ATTO
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by GOLDMAN SACHS GROUP INC since 04 Sep 2025
Reported holdings for GOLDMAN SACHS GROUP INC in Attovia Therapeutics, Inc.
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,020,632
- Estimated value
- $57,935,722
- Report date
- 06 Aug 2026
- Price
- $19.18
- Ownership
- Indirect
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Equity Swap
- Shares / value
- 105,807
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former 10% Owner
Attovia Therapeutics, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for GOLDMAN SACHS GROUP INC in Attovia Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.